Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal
Phase 1
Completed
- Conditions
- Diabetes Mellitus Type 1
- Interventions
- Drug: BioChaperone insulin lispro
- First Posted Date
- 2015-01-26
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- Adocia
- Target Recruit Count
- 38
- Registration Number
- NCT02344992
- Locations
- 🇩🇪
Profil GmbH, Neuss, Germany
A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer
Phase 3
Completed
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Other: Standard of Care
- First Posted Date
- 2014-09-11
- Last Posted Date
- 2017-06-29
- Lead Sponsor
- Adocia
- Target Recruit Count
- 252
- Registration Number
- NCT02236793
- Locations
- 🇮🇳
Dr Jivraj Mehta Smarak Health Foundation, Ahmedabad, India
🇮🇳IPGME & R and SSKM Hospital, Kolkata, India
🇮🇳V.S. General Hospital & Sml NHL Municipal Medical College Sheth, Ahmedabad, India
A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes
Phase 1
Completed
- Conditions
- Diabetes Mellitus Type 1
- Interventions
- First Posted Date
- 2014-08-11
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- Adocia
- Target Recruit Count
- 38
- Registration Number
- NCT02213146
- Locations
- 🇩🇪
Profil GmbH, Neuss, Germany
A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes
Phase 2
Completed
- Conditions
- Diabetes Mellitus Type 1
- Interventions
- Drug: BioChaperone insulin lispro 0.2U/KgDrug: BioChaperone insulin lispro 0.1U/KgDrug: BioChaperone insulin lispro 0.4U/Kg
- First Posted Date
- 2014-05-26
- Last Posted Date
- 2014-12-10
- Lead Sponsor
- Adocia
- Target Recruit Count
- 38
- Registration Number
- NCT02146651
- Locations
- 🇩🇪
Profil Institut für stoffwechselforschung GmbH, Neuss, Germany
A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes
Phase 1
Completed
- Conditions
- Diabetes Mellitus Type 1
- Interventions
- Drug: BioChaperone insulin lispro
- First Posted Date
- 2014-01-08
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- Adocia
- Target Recruit Count
- 37
- Registration Number
- NCT02029924
A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes
Phase 1
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 1
- Interventions
- Drug: BioChaperone® Combo
- First Posted Date
- 2013-11-11
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- Adocia
- Target Recruit Count
- 21
- Registration Number
- NCT01981031
A Study of Insulin Lispro With BioChaperone Excipient in Healthy Participants
Phase 1
Completed
- Conditions
- Healthy Participants
- Interventions
- Drug: BC106 insulin lispro
- First Posted Date
- 2012-07-11
- Last Posted Date
- 2014-06-16
- Lead Sponsor
- Adocia
- Target Recruit Count
- 37
- Registration Number
- NCT01638325
- Locations
- 🇸🇬
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore, Singapore
© Copyright 2025. All Rights Reserved by MedPath